Drug-Related Hypercalcemia.

Anne-Lise Lecoq, Marine Livrozet, Anne Blanchard, Peter Kamenický

Endocrinology and metabolism clinics of North America 2021 Dec

filter terms:

This review focuses on the commonly prescribed medicaments that can be responsible for hypercalcemia, considering the prevalence, the predominant pathophysiological mechanisms, and the optimal medical management of each drug-induced hypercalcemia. Vitamin D supplements and 1α-hydroxylated vitamin D analogues increase intestinal calcium absorption, renal calcium reabsorption as well as bone resorption. In patients with hypoparathyroidism receiving recombinant human PTH, transient hypercalcemia can occur because of overtreatment, usually during acute illness. Thiazide-induced hypercalcemia is mainly explained by enhanced renal proximal calcium reabsorption, changing preexistent asymptomatic normocalcemic or intermittently hypercalcemic hyperparathyroidism into the classic hypercalcemic hyperparathyroidism. Lithium causes hypercalcemia mainly by drug-induced hyperparathyroidism. Copyright © 2021 Elsevier Inc. All rights reserved.

Citation

Anne-Lise Lecoq, Marine Livrozet, Anne Blanchard, Peter Kamenický. Drug-Related Hypercalcemia. Endocrinology and metabolism clinics of North America. 2021 Dec;50(4):743-752